|Grant Affiliation:||Walker: bNabs after Infection and Immunization|
|Strategy:||Prophylactic neutralizing Ab|
|Study Type:||Antibody Screening|
|Study Start Date:||2013-03-11|
|Study Made Public:||2013-10-16|
Development of broadly neutralizing antibodies in HIV infection and following immunization
CAVD 413 is an immunogenicity study to evaluate the neutralization activity of monoclonal antibodies isolated from the plasma of Clade B HIV-infected individuals in US and German cohorts.
Sign in to see full information about this study and to download study data.
ProductsNo Products used in study
No integrated data is available for this study.
No non-integrated data is available for this study.